MustGrow Biologics Corp.
MGROF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1 | $3 | $4 | $0 |
| % Growth | -72.3% | -24.7% | 3,082.5% | – |
| Cost of Goods Sold | $1 | $2 | $3 | $0 |
| Gross Profit | $0 | $1 | $1 | $0 |
| % Margin | 17.9% | 20.9% | 14.3% | 21.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $2 | $1 | $1 | $1 |
| SG&A Expenses | $2 | $1 | $2 | $1 |
| Sales & Mktg Exp. | $1 | $1 | $1 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3 | $2 | $2 | $1 |
| Operating Income | -$2 | -$1 | -$1 | -$1 |
| % Margin | -306.9% | -34.2% | -39% | -1,046% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | $0 |
| Pre-Tax Income | -$2 | -$1 | -$2 | -$1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2 | -$1 | -$2 | -$1 |
| % Margin | -221% | -38.2% | -43.4% | -1,020.7% |
| EPS | -0.032 | -0.021 | -0.032 | -0.016 |
| % Growth | -52.6% | 34.3% | -95.1% | – |
| EPS Diluted | -0.032 | -0.021 | -0.032 | -0.016 |
| Weighted Avg Shares Out | 55 | 52 | 52 | 52 |
| Weighted Avg Shares Out Dil | 55 | 52 | 52 | 52 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $1 |
| EBITDA | -$2 | -$1 | -$2 | -$0 |
| % Margin | -305% | -35.9% | -42% | -143.1% |